Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

Delayed Data
As of Jun 30
 +0.88 / +2.07%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.

Contact Information

GlaxoSmithKline Plc
980 Great West Road
Brentford Greater London TW8 9GS
Investor Relations:



Other institutional6.64%
Mutual fund holders2.02%
Individual stakeholders--

Top Executives

Andrew Philip WittyChief Executive Officer & Executive Director
Simon DingemansChief Financial Officer & Executive Director
Nick HironsSenior VP-Global Ethics & Compliance Officer
Zhi HongSenior Vice President
Daniel E. TroySenior Vice President & General Counsel